InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,554.13
(
1.07%
)
US TECH 100
18,726.40
(
2.07%
)
Dow Jones
40,861.71
(
0.31%
)
Brent Oil
70.52
(
1.42%
)
Bitcoin
57,441.27
(
-0.39%
)
Post# of 62520
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

mick

Send PM Follow Ignore
Followers 3159
Posts 963694
Boards Moderated 192
Alias Born 09/04/2000

mick

Member Level

Re: mick post# 31150

Tuesday, 09/04/2007 9:09:39 AM

Tuesday, September 04, 2007 9:09:39 AM

Post# of 62520
7:36AM Zila Product selected to identify pre-cancer in study of leading cancer treatment chemotherapeutic -Erbitux (ZILA) 1.20 : Co announces it has been selected to identify pre-cancerous lesions in a Phase II study of Cetuximab (Erbitux), a cancer therapeutic for head and neck cancer developed by ImClone Systems (IMCL) and distributed by Bristol-Meyers Squibb (BMY).


http://finance.yahoo.com/marketupdate/inplay



Caspermick

"TOUGH TIMES NEVER LAST BUT TOUGH PEOPLE DO."


God Bless America

In Gambling,,,Playing Card Games. Ya Never Know What The Next Hand Will Look Like.
Ten Bagger Potential Stock

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up